Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PARTICLE-PRO

Financiado

Cerrado

Development of a hybrid process analytical technology to characterise the physic...

Development of a hybrid process analytical technology to characterise the physical and chemical properties of particles Particles and granules play a key role in process efficacy and final product quality for numerous industries including pharmaceuticals, food, nutritionals and cosmetics. Particle physics governs process variables such as flow, ble... ver más

30/11/2014

INNOPHARMA

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

INNOPHARMA LABS LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 8 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-11-30 No tenemos la información de la convocatoria

0% 77% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

8 Participantes

INNOPHARMA

0.00€ | Lider

INNVACIO I RECERCA INDUSTRIA...

N.D. | Participante

SUBLIMITY

N.D. | Participante

Proyectos interesantes

AMPLIACIÓN Y MEJORA DE LA CARTERA DE PRODUCTO...

Chemical Engine...

Materials Scien...

669K€ Cerrado

AMPLIACIÓN Y MEJORA DE LA CARTERA DE PRODUCTO...

Chemical Engine...

Materials Scien...

669K€ Cerrado

CRYSTAL-VIS

Chemical Engine...

Materials Scien...

2M€ Cerrado

POWTECH

Materials Scien...

Chemical Engine...

4M€ Cerrado

PharmaCrystEng

Chemical Engine...

Medical Technol...

152K€ Cerrado

PID2019-107665RJ-I00

Chemical Engine...

Materials Scien...

145K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

INNOPHARMA LABS LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Particles and granules play a key role in process efficacy and final product quality for numerous industries including pharmaceuticals, food, nutritionals and cosmetics. Particle physics governs process variables such as flow, blending, granulation, compression and coating. These variables can have a significant effect on final product behaviour such as blend homogeneity, drug absorption rates, product robustness, etc. The identified key physical parameters include particle/granule size and shape. Similarly the chemistry variation within the products has a critical effect on product quality. The current method of determining the end-point of pharmaceutical processes such as granulation is a combination of off-line or in-line analysis of size and shape characteristics and of moisture content and end product analysis of active content uniformity. The size and shape characteristics are important as they can significantly impact on compression processes. The moisture content is important as it can impact on compression processes and product stability (negatively leading to hydration of the active ingredient). The active content uniformity is important to ensure that each patient receives the correct dosage quantity. The development of one hybrid technology that is capable of assessing these three characteristics in real time will significantly advance pharmaceutical manufacturing control and assure greater product control and patient safety. This project aims to develop a technology that is a hybrid of imaging-based physical characterization and NIR-Chemical Imaging technologies that will provide physical and chemical granule characterisation in-line in a manufacturing process. The benefits for the pharmaceutical sector are increased granulation process control, increased process quality, increased batch yields, reduced downtime, reduced investigations due to deviation investigations, reduced risk of non-supply of products, greater assurance for regulatory bodies.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores